Plus   Neg

Stock Alert: Cassava Sciences To Report Q4 Results Today

Cassava Sciences, Inc. (SAVA), a clinical-stage biotechnology company, that develops drugs for nervous system disorders, is scheduled to report its fourth-quarter results today, March 23.

On average, analysts polled by Thomson Reuters expect the company to report loss of $0.13 per share.

In the third-quarter, the company had a positive earnings surprise of $0.04 loss per share compared with loss per share of $0.13 during the corresponding period last year.

The company's lead drug candidate is PTI-125 proposed for the treatment of Alzheimer's disease is in phase IIb study. Cassava expects to announce top-line results by mid-year 2020.

Cassava is also developing PTI-125Dx, a blood-based diagnostic to detect and monitor Alzheimer's disease.

The company, as a rule, gives updates on clinical trials during quarterly results.

Cassava Sciences ended the third quarter with $17.8 million of cash and equivalents, and no debt.

SAVA was down $0.36 or 8.51% on March 20, before closing at $3.87. It has traded in the range of $1.00- $10.95 in the last 52-weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada. Tyson Foods, Inc. (TSN) reported third quarter adjusted net income per share attributable to company of $1.40 compared to $1.47, a year ago. On average, 12 analysts polled by Thomson Reuters expected the company to report profit per share of $0.94, for the quarter. Analysts' estimates typically exclude...
Follow RTT